¥2.45   ( %)
前日收盘: 当日成交量(股): 当日最高: 总股本:642.12万
当日开盘: 当日成交额(元): 当日最低: 流通股本:
市盈率(动/静):0/0 市净率:0 市销率:0 总市值:1573.20万
52周最高:7.05 52周最低:2.32 转让方式: 单位:美元
$Sonoma Pharmaceuticals(SNOA)$
  • 还可以输入
  • 20016

Sonoma Pharmaceuticals(SNOA) 07月04日 23时36分

新闻 U.SK, dermatology arm of Brazilian NC Group, and Sonoma Pharmaceuticals Enter into License Agreement for Exclusive Rights to Sonoma’s Dermatology Products in Brazil U.SK, ......  url.vc.watch/gTZr
查看全文

Sonoma Pharmaceuticals(SNOA) 07月04日 23时36分

新闻 Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2018 Financial Results
Strong Annual Year-Over-Year Growth in Revenue of 30% $10 Million in Cash as of Ma ......  url.vc.watch/gTZJ
查看全文

Sonoma Pharmaceuticals(SNOA) 06月27日 05时58分

查看全文

Sonoma Pharmaceuticals(SNOA) 06月14日 05时54分

查看全文

Sonoma Pharmaceuticals(SNOA) 06月12日 13时48分

新闻 交易提示:Sonoma将于6月13日盘后公布2018财年年报
同花顺(300033)美股讯 Sonoma(股票代码:SNOA)将于6月13日盘后公布2018财年年报。SonomaPharmaceuticals,Inc.于1999年4月以Micromed科研实验股份有限公司的名字根据加利福尼亚州的法律成立。2001年8月,公司更名为Ocul ......  url.vc.watch/gUjz
查看全文

Sonoma Pharmaceuticals(SNOA) 06月05日 21时04分

查看全文

Sonoma Pharmaceuticals(SNOA) 06月04日 14时31分

新闻 Sonoma Pharmaceuticals Announces Fiscal Year/Fourth Quarter 2018 Financial Results and Conference Call PETALUMA, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmac ......  url.vc.watch/gsVD
查看全文

Sonoma Pharmaceuticals(SNOA) 06月02日 11时03分

公告 Sonoma Pharmaceuticals, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:MCLAUGHLIN JOHN
公告日:2018-06-01, 内部交易人:MCLAUGHLIN JOHN, 与发行人关系:/董事/, 操作码:A,1781(股)Common Stock, $0.0001 par value per share; 报告日:2018-05-30, SEC Accession No. 0001683168-18-001580, File:https://www.sec.gov/Archives/edgar/data/1367083/000168316818001580/0001683168-18-001580-index.htm $Sonoma Pharmaceuticals(SNOA)$
查看全文

Sonoma Pharmaceuticals(SNOA) 06月02日 11时03分

公告 Sonoma Pharmaceuticals, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Harrison Russell Joseph
公告日:2018-06-01, 内部交易人:Harrison Russell Joseph, 与发行人关系:/董事/, 操作码:A,1538(股)Common Stock, $0.0001 par value per share; 报告日:2018-05-30, SEC Accession No. 0001683168-18-001579, File:https://www.sec.gov/Archives/edgar/data/1367083/000168316818001579/0001683168-18-001579-index.htm $Sonoma Pharmaceuticals(SNOA)$
查看全文

Sonoma Pharmaceuticals(SNOA) 06月02日 11时03分

公告 Sonoma Pharmaceuticals, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Birnbaum Jay E
公告日:2018-06-01, 内部交易人:Birnbaum Jay E, 与发行人关系:/董事/, 操作码:A,1052(股)Common Stock, $0.0001 par value per share; 报告日:2018-05-30, SEC Accession No. 0001683168-18-001578, File:https://www.sec.gov/Archives/edgar/data/1367083/000168316818001578/0001683168-18-001578-index.htm $Sonoma Pharmaceuticals(SNOA)$
查看全文

Sonoma Pharmaceuticals(SNOA) 05月12日 15时20分

新闻 Sonoma Pharmaceuticals Names Marc Umscheid Chief Operating Officer
PETALUMA, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a spec ......  url.vc.watch/ffJN
查看全文

Sonoma Pharmaceuticals(SNOA) 04月17日 22时54分

新闻 Sonoma Pharmaceuticals Receives Four New UAE Regulatory Approvals that Include Acne and Anti-Fungal Products PETALUMA, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Sonoma ......  url.vc.watch/XBFz
查看全文

Sonoma Pharmaceuticals(SNOA) 04月09日 09时15分

新闻 Sonoma Pharmaceuticals Announces FDA Approval for Antimicrobial Post-Therapy Gel
PETALUMA, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasd ......  url.vc.watch/XmPU
查看全文

Sonoma Pharmaceuticals(SNOA) 04月01日 17时33分

新闻 Sonoma Pharmaceuticals Introduces New and Improved Acuicyn™ Antimicrobial Eyelid and Eyelash Hygiene Solution PETALUMA, Calif., March 27, 2018 (GLOBE NEWSWIRE) -- Sonom ......  url.vc.watch/B1HW
查看全文

Sonoma Pharmaceuticals(SNOA) 03月15日 10时58分

公告 Sonoma Pharmaceuticals, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Miller Robert E
公告日:2018-03-14, 内部交易人:Miller Robert E, 与发行人关系:Chief Financial Officer/高管/, 操作:买入,2400(股)Common Stock, $0.0001 par value per share,均价$4.0648; 报告日:2018-03-12, SEC Accession No. 0001683168-18-000672, File:https://www.sec.gov/Archives/edgar/data/1367083/000168316818000672/0001683168-18-000672-index.htm $Sonoma Pharmaceuticals(SNOA)$
查看全文

Sonoma Pharmaceuticals(SNOA) 03月14日 05时47分

公告 Sonoma Pharmaceuticals, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Miller Robert E
公告日:2018-03-13, 内部交易人:Miller Robert E, 与发行人关系:Chief Financial Officer/高管/, 操作:买入,2400(股)Common Stock, $0.0001 par vlue per share,均价$3.9650; 报告日:2018-03-09, SEC Accession No. 0001683168-18-000658, File:https://www.sec.gov/Archives/edgar/data/1367083/000168316818000658/0001683168-18-000658-index.htm $Sonoma Pharmaceuticals(SNOA)$
查看全文

Sonoma Pharmaceuticals(SNOA) 03月14日 03时41分

新闻 Sonoma Pharmaceuticals Receives Three New United Arab Emirates Regulatory Approvals: Acuicyn® for Management of Blepharitis, Microsafe® Oral Care for Mucositis ......  url.vc.watch/BUVC
查看全文

Sonoma Pharmaceuticals(SNOA) 03月14日 03时41分

新闻 Sonoma Pharmaceuticals Announces Fiscal Third Quarter 2018 Financial Results and Conference Call
PETALUMA, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceutic ......  url.vc.watch/BUVs
查看全文

Sonoma Pharmaceuticals(SNOA) 03月14日 03时41分

新闻 Sonoma Pharmaceuticals, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 7, 2018 / Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) will be discussing their e ......  url.vc.watch/BUVG
查看全文

Sonoma Pharmaceuticals(SNOA) 03月14日 03时41分

新闻 Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46% Product revenue up 12% com ......  url.vc.watch/BUVm
查看全文
  • 首页 上一页 1 2 下一页 尾页  每页20条/共24